Berlin - Delayed Quote EUR
AcelRx Pharmaceuticals Inc (R5XA.BE)
0.4560
-0.0050
(-1.08%)
At close: May 14 at 9:40:06 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
651
0
2,818
Cost of Revenue
--
--
--
2,591
3,753
Gross Profit
--
--
--
-820
-935
Operating Expense
15,252
15,252
17,540
20,352
35,030
Operating Income
-15,252
-15,252
-16,889
-20,352
-35,965
Net Non Operating Interest Income Expense
285
285
1,282
386
871
Other Income Expense
1,963
1,963
5,320
79,104
--
Pretax Income
-13,004
-13,004
-10,287
59,138
-35,094
Tax Provision
--
--
0
13
5
Net Income Common Stockholders
-13,004
-13,004
-18,397
42,329
-35,099
Diluted NI Available to Com Stockholders
-13,004
-13,004
-18,397
42,342
-35,099
Basic EPS
-0.50
--
-1.29
5.73
-5.80
Diluted EPS
-0.50
--
-1.29
5.72
-5.80
Basic Average Shares
25,845.6390
--
14,263.7440
7,385.3480
5,993
Diluted Average Shares
25,845.6390
--
14,263.7440
7,406.9860
5,993
Total Operating Income as Reported
-15,252
-15,252
-16,889
-25,300
-35,965
Total Expenses
15,252
15,252
17,540
20,352
38,783
Net Income from Continuing & Discontinued Operation
-13,004
-13,004
-18,397
47,755
-35,099
Normalized Income
-14,967
-14,967
-15,607
-19,961.6110
-35,099
Interest Income
679
679
1,416
1,502
3,162
Interest Expense
394
394
134
1,116
2,291
Net Interest Income
285
285
1,282
386
871
EBIT
-12,610
-12,610
-10,153
60,254
-32,803
EBITDA
-12,610
-12,610
-9,842
61,901
-30,830
Reconciled Cost of Revenue
--
--
--
2,591
3,753
Reconciled Depreciation
0
0
311
1,647
1,973
Net Income from Continuing Operation Net Minority Interest
-13,004
-13,004
-10,287
59,125
-35,099
Total Unusual Items Excluding Goodwill
1,963
1,963
5,320
79,104
0
Total Unusual Items
1,963
1,963
5,320
79,104
0
Normalized EBITDA
-14,573
-14,573
-15,162
-17,203
-30,830
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
0
0
0
17.3890
0
12/31/2021 - 9/23/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade